ACSS2 and breast carcinoma: Importantly, silencing the nuclear-cytosolic isoform of AcCoA synthetase (ACSS2), which converts acetate to AcCoA, reduced tumor growth in a xenograft model of breast cancer (Schug et al., 2015).